Literature DB >> 16166046

Osteoporosis at presentation of childhood ALL: management with pamidronate.

Ellen B Goldbloom1, Elizabeth A Cummings, Margaret Yhap.   

Abstract

Vertebral fractures at diagnosis of childhood acute lymphoblastic leukemia (ALL) are an uncommon but recognized problem. Clinical issues associated with pathological fractures in these children include pain control and the potential for further treatment-associated fractures and long-term bony morbidity. The authors report the successful use of pamidronate in two children who presented with vertebral compression fractures at diagnosis of ALL. Both patients had pain and low bone mineral density at baseline. In addition to standard chemotherapy, pamidronate (1 mg/kg, IV) was given bimonthly. Initial rapid symptom relief and gradual improvement of bone mineral density was demonstrated in both patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166046     DOI: 10.1080/08880010500198285

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  10 in total

1.  Vertebral compression fractures during chemotherapy for childhood acute lymphoblastic leukemia: commentary on a report from the STeroid Associated Osteoporosis in the Pediatric Population (STOPP) research program.

Authors:  Kirsten K Ness; Wassim Chemaitilly; Sue C Kaste
Journal:  Transl Pediatr       Date:  2012-10

2.  Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Authors:  Jae Min Lee; Ji Eun Kim; Soon Hwan Bae; Jeong Ok Hah
Journal:  Blood Res       Date:  2013-06-25

3.  Bone mineral density after bone marrow transplantation in childhood: measurement and associations.

Authors:  Kathy Ruble; Matthew J Hayat; Kerry J Stewart; Allen R Chen
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

Review 4.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

5.  Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukaemia.

Authors:  A M Harris; A R Lee; S C Wong
Journal:  Osteoporos Int       Date:  2019-08-03       Impact factor: 4.507

6.  Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies.

Authors:  N A Greggio; M Pillon; E Varotto; A Zanin; E Talenti; A C Palozzo; E Calore; C Messina
Journal:  Case Rep Med       Date:  2010-06-10

Review 7.  Imaging of back pain in children.

Authors:  D P Rodriguez; T Y Poussaint
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-19       Impact factor: 3.825

Review 8.  Bisphosphonate therapy for children and adolescents with secondary osteoporosis.

Authors:  L Ward; A C Tricco; P Phuong; A Cranney; N Barrowman; I Gaboury; F Rauch; P Tugwell; D Moher
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Bone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management.

Authors:  Min Jae Kang; Jung Sub Lim
Journal:  Korean J Pediatr       Date:  2013-02-25

10.  The boy who refused an IV: a case report of subcutaneous clodronate for bone pain in a child with Ewing Sarcoma.

Authors:  Harold Siden
Journal:  J Med Case Rep       Date:  2007-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.